Ergoteles’s Dynavax Technologies DVAX Stock Holding History

Ergoteles’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,842	Closed	-$234K	–	1143
2023 Q1	$234K	Sell	23,842 -13,262	-36%	-$142K	0.01%	964
2022 Q4	$395K	Buy	+37,104	New	+$431K	0.01%	797

Other funds holding DVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ergoteles's DVAX Position: Q2 2023 in Review

Ergoteles sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 23,842 shares — an estimated $234K sold.

Ergoteles first reported a position in DVAX in Q4 2022 and held it in 2 quarters. The position peaked at $395K in Q4 2022. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

Ergoteles reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 23,842 Dynavax Technologies shares in Q2 2023, an estimated $234K.
Ergoteles first reported a position in Dynavax Technologies in Q4 2022 and held it in 2 quarters.
Ergoteles's Dynavax Technologies position peaked at $395K in Q4 2022.
215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.